Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium

Li, Ling; Xu-Monette, Zijun Y.; Ok, Chi Y.; Manyam, Ganiraju C.; Visco, Carlo; Tzankov, Alexander; Montes-Moreno, Santiago; Dybkær, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; Richards, Kristy L.; Hsi, Eric D.; Choi, William W.L.; Han van Krieken, J.; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J.M.; Farnen, John P.; Møller, Michael B.; Piris, Miguel A.; Winter, Jane N.; Medeiros, L. Jeffrey; Young, Ken H.

期刊名称Clinical Lymphoma Myeloma and Leukemia
作者Li, Ling; Xu-Monette, Zijun Y.; Ok, Chi Y.; Manyam, Ganiraju C.; Visco, Carlo; Tzankov, Alexander; Montes-Moreno, Santiago; Dybkær, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; Richards, Kristy L.; Hsi, Eric D.; Choi, William W.L.; Han van Krieken, J.; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J.M.; Farnen, John P.; Møller, Michael B.; Piris, Miguel A.; Winter, Jane N.; Medeiros, L. Jeffrey; Young, Ken H.
卷第15卷
印刷ISSN2152-2650
文件大小67.34KB
发表时间2015-06
DOI10.1016/j.clml.2015.04.101

发现好书期刊，享受阅读乐趣

Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium